The Latest in HIV

Infectious Disease Practitioner

New WHO recommendations promote dolutegravir benefits in the face of lowered risk signal for neural tube defects

July 22, 2019

HIV

Infectious Disease Practitioner

More than half of U.S. adults have never received HIV screening

June 27, 2019

HIV

USPSTF recommends PrEP combo for adults at high risk of HIV infection

June 11, 2019

HIV

Infectious Disease Practitioner

Consider measles vaccine booster in HIV-positive patients

June 4, 2019

Infectious Disease Practitioner

Zero HIV transmission rate when viral load suppressed

May 8, 2019

HIV

Infectious Disease Practitioner

ICYMI: Anti-CD4 antibody maintains viral suppression in HIV patients post ART

April 17, 2019

HIV

Infectious Disease Practitioner

Dolutegravir passes late pregnancy test

April 12, 2019

HIV

Infectious Disease Practitioner

Weight gain highest with integrase inhibitors for HIV

April 11, 2019

HIV

Infectious Disease Practitioner

FDA approves first two-drug tablet for HIV

April 8, 2019

HIV

Infectious Disease Practitioner

Nucleic acid testing before PrEP urged to detect occult HIV

April 5, 2019

HIV

Infectious Disease Practitioner

PrEP adherence lowest among Medicaid patients, others

April 4, 2019

HIV

Infectious Disease Practitioner

Harness EHRs to identify PrEP candidates

April 3, 2019

HIV

Infectious Disease Practitioner

Genetic data boost HIV surveillance efforts

April 3, 2019

HIV

Infectious Disease Practitioner

STIs pose complex challenge to HIV efforts

April 3, 2019

HIV

Infectious Disease Practitioner

Noninfected children of HIV-positive mothers have high rates of obesity

April 2, 2019